PubRank

Veronica Huber

Author PubWeight™ 34.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 2007 6.68
2 High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009 3.10
3 Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002 3.02
4 Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007 2.80
5 Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 2006 2.61
6 Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother 2011 1.94
7 Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction. Immunol Rev 2002 1.66
8 Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012 1.46
9 Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 2012 1.45
10 Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res 2012 1.41
11 Immune surveillance properties of human NK cell-derived exosomes. J Immunol 2012 1.26
12 IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 2004 1.22
13 More insights into the immunosuppressive potential of tumor exosomes. J Transl Med 2008 1.14
14 Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells. J Immunol 2003 1.06
15 Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J Leukoc Biol 2005 1.05
16 Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opin Biol Ther 2005 1.02
17 Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol 2004 1.01
18 Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Cancer Res 2005 0.84
19 Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy. J Transl Med 2011 0.75